Cencora, Inc.
COR Stock News
Latest COR news
Here's Why Cencora (COR) is a Strong Growth Stock
Zacks Investment Research · Wed, 23 Sep 2026 10:45:50 -0400
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027
MarketBeat · Mon, 21 Sep 2026 19:02:30 -0400
Cencora NYSE: COR executives said the company expects its specialty-focused strategy to support continued growth into fiscal 2027, citing demand in oncology and retina, expanded physician-services capabilities and momentum in its international businesses.
Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference
MarketBeat · Mon, 21 Sep 2026 06:02:57 -0400
Cencora NYSE: COR executives highlighted the company's specialty pharmaceutical positioning, medical specialty organization strategy and capital-allocation priorities during an investor conference discussion, while reaffirming the durability of its relationship with Walgreens.
Here's Why Cencora (COR) is a Strong Value Stock
Zacks Investment Research · Fri, 18 Sep 2026 10:41:18 -0400
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cencora, Inc. (COR) Presents at 2026 Global Healthcare Conference Transcript
Seeking Alpha · Tue, 15 Sep 2026 18:01:37 -0400
Cencora, Inc. (COR) Presents at 2026 Global Healthcare Conference Transcript
Cencora, Inc. (COR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha · Tue, 15 Sep 2026 11:01:39 -0400
Cencora, Inc. (COR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Here's Why Cencora (COR) is a Strong Momentum Stock
Zacks Investment Research · Thu, 10 Sep 2026 10:50:56 -0400
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Market information is provided for research and visualization and is not investment advice.